Corcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
MENLO PARK, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…
Börse:
20,116$
-0,86%
Echtzeit-Aktienkurs Corcept Therapeutics Inc.
Bid:
19,966$
Ask:
20,266$
Nachrichten zur Corcept Therapeutics Inc. Aktie
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
MENLO PARK, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will…
Corcept Therapeutics Completes Enrollment in Controlled, Phase 2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Ovarian Cancer
MENLO PARK, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…
CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Corcept Therapeutics: A Long-Term Hold Despite Short-Term Sales Threat
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics initiates late-study for Relacorilant doublet therapy in pancreatic cancer
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…
Should You Climb on Board the Corcept Therapeutics Train-
This biotech company has seen huge growth over the past five years....…
Corcept Therapeutics Incorporated (CORT) Q1 2020 Earnings Call Transcript
CORT earnings call for the period ending March 31, 2020....…
Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff on Q1 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics (CORT) Tops Q1 Earnings and Revenue Estimates
Corcept (CORT) delivered earnings and revenue surprises of 19.05% and 7.35%, respectively, for the quarter ended March 2020. Do the…
Corcept Therapeutics EPS beats by $0.13, beats on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update
MENLO PARK, Calif. , May 04, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company…
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
MENLO PARK, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will…
Are You Looking for a Top Momentum Pick- Why Corcept Therapeutics (CORT) is a Great Choice
Does Corcept Therapeutics (CORT) have what it takes to be a top stock pick for momentum investors? Lets find out....…
Corcept Therapeutics Shares March Higher, Can It Continue-
As of late, it has definitely been a great time to be an investor in Corcept Therapeutics....…
Why You Shouldnt Bet Against Corcept Therapeutics (CORT) Stock
Corcept Therapeutics (CORT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry…
CORCEPT THERAPEUTICS PUBLISHES ABSTRACT IN THE JOURNAL OF THE ENDOCRINE SOCIETY
MENLO PARK, Calif., April 01, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…
Corcept (CORT) Q4 Earnings In-Line with Estimates, Up Y/Y
Corcept Therapeutics (CORT) reports in-line earnings in the fourth quarter of 2020....…
Corcept Therapeutics Incorporated (CORT) Q4 2019 Earnings Call Transcript
CORT earnings call for the period ending December 31, 2019....…
Corcept Therapeutics, Inc. (CORT) CEO Joseph Belanoff on Q4 2019 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics (CORT) Meets Q4 Earnings Estimates
Corcept (CORT) delivered earnings and revenue surprises of 0.00% and -0.01%, respectively, for the quarter ended December 2019. Do the…
Corcept Therapeutics reports preliminary Q4 results
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Despite The Clouds Hanging Over Korlym Sales, Corcept Therapeutics Still Looks An Attractive Investment
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…